Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 1,2 Diol. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101704711A reveals solvent-free fluoroboric acid catalysis for high-purity 1,2-diol production, offering substantial cost reduction and supply chain reliability for global manufacturers.
Patent CN1122658C details advanced isoserinol purification achieving ultra-low impurities for contrast agents. Offers supply chain stability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN108033942B reveals a metal-free catalytic route for co-producing 3,3,3-trifluoro-1,2-propanediol and 4-trifluoromethyl ethylene carbonate with adjustable distribution and high atom economy.
Patent CN102942451A details a green method for 1,2-diol production using recyclable selenium polymers, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN104726355B reveals yeast spore technology for high-purity chiral intermediates with enhanced stability and supply chain reliability for global pharmaceutical manufacturing partners.
Patent CN113603574B reveals a novel silicotungstic catalyst for cyclopentene oxidation offering high yield and recyclability for industrial glutaraldehyde manufacturing.
Novel Pd-catalyzed asymmetric double oxidation for high-purity pharmaceutical intermediates. Cost-effective, scalable route with superior enantioselectivity.
Patent CN108753851B details a novel ChKRED12 enzyme method for producing high-purity chiral 1,2-diols, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel route using butylene glycol derivatives offers high yield and scalability for pharmaceutical intermediates, reducing raw material costs significantly.
Patent CN105624214A reveals high-efficiency enzymatic synthesis. Offers supply chain stability and cost reduction in agrochemical intermediate manufacturing without heavy metals.
Discover a cost-effective, non-toxic synthesis method for 1,2-vicinal diols with >85% yield. Eliminate heavy metal catalysts and scale-up risks for pharmaceutical intermediates.